These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27992879)

  • 21. Discovery of novel lysine ɛ-aminotransferase inhibitors: An intriguing potential target for latent tuberculosis.
    Devi PB; Sridevi JP; Kakan SS; Saxena S; Jeankumar VU; Soni V; Anantaraju HS; Yogeeswari P; Sriram D
    Tuberculosis (Edinb); 2015 Dec; 95(6):786-794. PubMed ID: 26299907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Target DNA stabilizes Mycobacterium tuberculosis DevR/DosR phosphorylation by the full-length oxygen sensors DevS/DosS and DosT.
    Sousa EHS; Gonzalez G; Gilles-Gonzalez MA
    FEBS J; 2017 Nov; 284(22):3954-3967. PubMed ID: 28977726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of ATP binding for the autophosphorylation of DosS, a Mycobacterium tuberculosis histidine kinase lacking an ATP lid motif.
    Cho HY; Lee YH; Bae YS; Kim E; Kang BS
    J Biol Chem; 2013 May; 288(18):12437-47. PubMed ID: 23486471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel drug discovery concept for tuberculosis: inhibition of bacterial and host cell signalling.
    Székely R; Wáczek F; Szabadkai I; Németh G; Hegymegi-Barakonyi B; Eros D; Szokol B; Pató J; Hafenbradl D; Satchell J; Saint-Joanis B; Cole ST; Orfi L; Klebl BM; Kéri G
    Immunol Lett; 2008 Mar; 116(2):225-31. PubMed ID: 18258308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DosT and DevS are oxygen-switched kinases in Mycobacterium tuberculosis.
    Sousa EH; Tuckerman JR; Gonzalez G; Gilles-Gonzalez MA
    Protein Sci; 2007 Aug; 16(8):1708-19. PubMed ID: 17600145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NU-6027 Inhibits Growth of Mycobacterium tuberculosis by Targeting Protein Kinase D and Protein Kinase G.
    Kidwai S; Bouzeyen R; Chakraborti S; Khare N; Das S; Priya Gosain T; Behura A; Meena CL; Dhiman R; Essafi M; Bajaj A; Saini DK; Srinivasan N; Mahajan D; Singh R
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31285226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognate sensor kinase-independent activation of Mycobacterium tuberculosis response regulator DevR (DosR) by acetyl phosphate: implications in anti-mycobacterial drug design.
    Sharma S; Kumari P; Vashist A; Kumar C; Nandi M; Tyagi JS
    Mol Microbiol; 2019 May; 111(5):1182-1194. PubMed ID: 30589958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Overview on the Potential Antimycobacterial Agents Targeting Serine/Threonine Protein Kinases from Mycobacterium tuberculosis.
    Mori M; Sammartino JC; Costantino L; Gelain A; Meneghetti F; Villa S; Chiarelli LR
    Curr Top Med Chem; 2019; 19(9):646-661. PubMed ID: 30827246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-throughput screen identifies small molecule inhibitors targeting acetyltransferase activity of Mycobacterium tuberculosis GlmU.
    Rani C; Mehra R; Sharma R; Chib R; Wazir P; Nargotra A; Khan IA
    Tuberculosis (Edinb); 2015 Dec; 95(6):664-677. PubMed ID: 26318557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A spectroelectrochemical investigation of the heme-based sensor DevS from Mycobacterium tuberculosis: a redox versus oxygen sensor.
    Barreto GA; Carepo MSP; Gondim ACS; Guimarães WG; Lopes LGF; Bernhardt PV; Paulo TF; Sousa EHS; Diógenes ICN
    FEBS J; 2019 Nov; 286(21):4278-4293. PubMed ID: 31254441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure guided lead generation for M. tuberculosis thymidylate kinase (Mtb TMK): discovery of 3-cyanopyridone and 1,6-naphthyridin-2-one as potent inhibitors.
    Naik M; Raichurkar A; Bandodkar BS; Varun BV; Bhat S; Kalkhambkar R; Murugan K; Menon R; Bhat J; Paul B; Iyer H; Hussein S; Tucker JA; Vogtherr M; Embrey KJ; McMiken H; Prasad S; Gill A; Ugarkar BG; Venkatraman J; Read J; Panda M
    J Med Chem; 2015 Jan; 58(2):753-66. PubMed ID: 25486447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hit discovery of Mycobacterium tuberculosis inosine 5'-monophosphate dehydrogenase, GuaB2, inhibitors.
    Sahu NU; Singh V; Ferraris DM; Rizzi M; Kharkar PS
    Bioorg Med Chem Lett; 2018 Jun; 28(10):1714-1718. PubMed ID: 29699922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery and structure optimization of a series of isatin derivatives as Mycobacterium tuberculosis chorismate mutase inhibitors.
    Jeankumar VU; Alokam R; Sridevi JP; Suryadevara P; Matikonda SS; Peddi S; Sahithi S; Alvala M; Yogeeswari P; Sriram D
    Chem Biol Drug Des; 2014 Apr; 83(4):498-506. PubMed ID: 24636345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The emerging role of gasotransmitters in the pathogenesis of tuberculosis.
    Chinta KC; Saini V; Glasgow JN; Mazorodze JH; Rahman MA; Reddy D; Lancaster JR; Steyn AJ
    Nitric Oxide; 2016 Sep; 59():28-41. PubMed ID: 27387335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein kinases as antibacterial targets.
    Schreiber M; Res I; Matter A
    Curr Opin Cell Biol; 2009 Apr; 21(2):325-30. PubMed ID: 19246185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Putative histidine kinase inhibitors with antibacterial effect against multi-drug resistant clinical isolates identified by in vitro and in silico screens.
    Velikova N; Fulle S; Manso AS; Mechkarska M; Finn P; Conlon JM; Oggioni MR; Wells JM; Marina A
    Sci Rep; 2016 May; 6():26085. PubMed ID: 27173778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigating the inhibitory potential of 2-Aminopurine metal complexes against serine/threonine protein kinases from Mycobacterium tuberculosis.
    Bais VS; Mohapatra B; Ahamad N; Boggaram S; Verma S; Prakash B
    Tuberculosis (Edinb); 2018 Jan; 108():47-55. PubMed ID: 29523327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and structure-activity relationship study of carvacrol derivatives as Mycobacterium tuberculosis chorismate mutase inhibitors.
    Alokam R; Jeankumar VU; Sridevi JP; Matikonda SS; Peddi S; Alvala M; Yogeeswari P; Sriram D
    J Enzyme Inhib Med Chem; 2014 Aug; 29(4):547-54. PubMed ID: 24090423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elaboration of a proprietary thymidylate kinase inhibitor motif towards anti-tuberculosis agents.
    Song L; Risseeuw MDP; Froeyen M; Karalic I; Goeman J; Cappoen D; Van der Eycken J; Cos P; Munier-Lehmann H; Van Calenbergh S
    Bioorg Med Chem; 2016 Nov; 24(21):5172-5182. PubMed ID: 27614917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distal Hydrogen-bonding Interactions in Ligand Sensing and Signaling by Mycobacterium tuberculosis DosS.
    Basudhar D; Madrona Y; Yukl ET; Sivaramakrishnan S; Nishida CR; Moënne-Loccoz P; Ortiz de Montellano PR
    J Biol Chem; 2016 Jul; 291(31):16100-11. PubMed ID: 27235395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.